Partners Capital Investment Group LLP significantly expanded its investment in Eli Lilly and Company, nearly doubling its position in the pharmaceutical giant. According to the firm’s latest regulatory filing, it now owns over 2,000 shares in the company, demonstrating a notable vote of confidence in this healthcare leader.